cell - International Pharmaceutical Industry

Volume 15 Issue 2

Advancements of Gene Editing Technologies(CRISPR/Cas9)

An Introduction to Gene Editing – CRISPR-Cas9 The dynamic promise of gene editing for humans is the ability to precisely manipulate the sequence of the cell genom...

3 July 2023 Volume 15 Issue 2 Advancements | cell

Continue Reading →

Volume 15 Issue 2

Gene Edited iPSCs May Find a Place in Allogeneic Therapies

An Introduction to Pluripotency Pluripotent: adjective; capable of giving rise to many different cell types. This is the hallmark characteristic of the induced pl...

3 July 2023 Volume 15 Issue 2 allogeneic | cell

Continue Reading →

News

Bioprocessing Technologies in Stem Cell Research

The 2nd Stem Cell Community Day brings together experts from industry and academia to discuss recent achievements, challenges, and chances in stem cel...

27 March 2018 News bioprocessing | cell

Continue Reading →

News

SYGNIS AG signs supply agreement with US Biological for the Lightning-Link antibody labelling technology

SYGNIS AG, the Group which includes Expedeon Holdings, Innova Biosciences, and C.B.S. Scientific Company, today announced it has signed a supply agreement with ...

28 November 2017 News antibody | biological

Continue Reading →

News

Symcel secures €3.6 million Horizon 2020 Phase II grant for clinical validation of customized antimicrobial susceptibility testing

Symcel, the company behind the revolutionary cell-based assay tool for real-time cell metabolism measurements, calScreener™, has secured €3.572 million Horizon 2020 ...

21 November 2017 News antibiotic | assay

Continue Reading →

News

Elpis BioMed closes funding round to commercialise novel technology platform for generating human cell types

Elpis BioMed Ltd (Elpis), a University of Cambridge spin-out, applying its disruptive and proprietary “direct cell reprogramming” platform to produce pure, mature an...

20 November 2017 News application | cell

Continue Reading →

News

Genmab Achieves USD 50 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen

Genmab has announced that it has achieved a USD 50 million sales volume milestone in its DARZALEX® (daratumumab) collaboration with Janssen Biotech, Inc. The m...

17 November 2017 News antibody | cancer

Continue Reading →

News

IDBS takes Bioprocess Execution Solution to the Cloud

IDBS announces the release of its latest Bioprocess Execution (BPES) informatics solution. Leveraging the IDBS E-WorkBook Cloud platform, the solution provides an ou...

9 November 2017 News bioprocess | cell

Continue Reading →